Prognostic Value of Necroptosis-Related Genes Signature in Oral Squamous Cell Carcinoma

被引:3
|
作者
Huang, Ke [1 ,2 ]
Gu, Xiaoting [1 ,2 ]
Xu, Huimei [3 ]
Li, Hui [2 ]
Shi, Mingxuan [2 ]
Wei, Defang [1 ,2 ]
Wang, Shiqi [2 ]
Li, Yao [4 ]
Liu, Bin [2 ]
Li, Yi [2 ]
机构
[1] Lanzhou Univ, Sch Basic Med Sci, Key Lab Preclin Study New Drugs Gansu Prov, Lanzhou 730030, Peoples R China
[2] Lanzhou Univ, Sch Stomatol, Key Lab Dent Maxillofacial Reconstruct & Biol Inte, Lanzhou 730030, Peoples R China
[3] Lanzhou Univ, Hosp 2, Lanzhou 730030, Peoples R China
[4] Third Peoples Hosp Gansu Prov, Lanzhou 730030, Peoples R China
关键词
necroptosis; HPRT1; prognostic signature; biomarker; oral squamous cell carcinoma; INFLAMMATION; HEAD;
D O I
10.3390/cancers15184539
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Simple Summary This study aimed to explore the relationship between necroptosis and oral squamous cell carcinoma (OSCC) preliminarily, and search for the novel prognostic factors for OSCC, in order to help guide the mechanism exploration, clinical diagnosis, targeted therapy, and prognosis of OSCC patients. The prognostic signature of necroptosis-related genes (NRGs) for OSCC has been constructed through relevant bioinformatics methods, which showed that HPRT1 can serve as a novel independent prognostic factor for OSCC. The experiments also validated that the knockdown of HPRT1 could suppress the proliferation and migration of OSCC cells. Furthermore, the relationship between necroptosis and OSCC has also been discussed, which suggests that necroptosis might promote the development and metastasis of OSCC by initiating inflammatory response and immunosuppression.Abstract The dual role of necroptosis in inhibiting and promoting tumor development has gradually received much attention because of its essential significance for targeted treatment. Accordingly, this study aims to explore the relationship between necroptosis and oral squamous cell carcinoma (OSCC), and search for novel prognostic factors for OSCC. RNA-seq data and clinical information were downloaded from TCGA and GTEx databases. The prognostic signature of necroptosis-related genes (NRGs) was constructed by univariate Cox regression analysis and the LASSO Cox regression model. Moreover, survival analyses, ROC curves, and nomograms were adopted to further analyze. GO and KEGG analyses and immune infiltration analyses were used for function enrichment and immune feature research in turn. The NRG prognostic signature expression was higher in OSCC tissues than in normal tissues, and the overall survival (OS) rate of the high-expression group was much lower. HPRT1 was proved to be an independent prognostic factor in OSCC. Furthermore, the function enrichment analyses revealed that NRGs were involved in necroptosis, apoptosis, inflammation, and immune reaction. The expression of NRGs was related to immunosuppression in OSCC. Furthermore, the knockdown of HPRT1 could suppress the proliferation and migration of OSCC. In conclusion, the high expression of NRG prognostic signature is associated with poor prognosis in OSCC, and HPRT1 can serve as a novel independent prognostic factor for OSCC.
引用
收藏
页数:19
相关论文
共 50 条
  • [31] Identification of a necroptosis-related gene signature as a novel prognostic biomarker of cholangiocarcinoma
    Xu, Lixia
    Gao, Xueping
    Xing, Jiyuan
    Guo, Zhixian
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [32] A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma
    Chenguang Zhao
    Yingrui Zhou
    Hongwei Ma
    Jinhui Wang
    Haoliang Guo
    Hao Liu
    BMC Oral Health, 21
  • [33] A four-hypoxia-genes-based prognostic signature for oral squamous cell carcinoma
    Zhao, Chenguang
    Zhou, Yingrui
    Ma, Hongwei
    Wang, Jinhui
    Guo, Haoliang
    Liu, Hao
    BMC ORAL HEALTH, 2021, 21 (01)
  • [34] Identification of Necroptosis-related Molecular Subtypes and Construction of Necroptosis-related Gene Signature for Glioblastoma Multiforme
    Li, Zhiyong
    Jin, Yinghui
    Que, Tianshi
    Zhang, Xi-an
    Yi, Guozhong
    Zheng, Haojie
    Yuan, Xi
    Wang, Xiaoyan
    Xu, Haiyan
    Nan, Jing
    Chen, Chao
    Wu, Yuankui
    Huang, Guanglong
    CURRENT MEDICINAL CHEMISTRY, 2024, 31 (33) : 5417 - 5431
  • [35] Establishment of a Necroptosis-Related Prognostic Signature to Reveal Immune Infiltration and Predict Drug Sensitivity in Hepatocellular Carcinoma
    Ren, Huili
    Zheng, Jianglin
    Cheng, Qi
    Yang, Xiaoyan
    Fu, Qin
    FRONTIERS IN GENETICS, 2022, 13
  • [36] Revealing the potential of necroptosis-related genes in prognosis, immune characteristics, and treatment strategies for head and neck squamous cell carcinoma
    Cao, Junhua
    Wu, Congxiao
    Han, Zhaofeng
    Liu, Zheng
    Yang, Zheng
    Ren, Minge
    Wang, Ximei
    SCIENTIFIC REPORTS, 2023, 13 (01):
  • [37] Prognostic model for hepatocellular carcinoma based on necroptosis-related genes and analysis of drug treatment responses
    Wu, Ronghuo
    Deng, Xiaoxia
    Wang, Xiaomin
    Li, Shanshan
    Su, Jing
    Sun, Xiaoyan
    HELIYON, 2024, 10 (17)
  • [38] Construction and validation of a necroptosis-related lncRNAs prognosis signature of hepatocellular carcinoma
    Peng, YunZhen
    Wu, GuoJing
    Qiu, Xin
    Luo, Yue
    Zou, YiShu
    Wei, XueYan
    Li, Aimin
    FRONTIERS IN GENETICS, 2022, 13
  • [39] Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma
    Tao, Qiqi
    Lang, Zhichao
    Li, Yifei
    Gao, Yuxiang
    Lin, Lifan
    Yu, Zhengping
    Zheng, Jianjian
    Yu, Suhui
    BMC CANCER, 2023, 23 (01)
  • [40] Exploration and validation of a novel signature of seven necroptosis-related genes to improve the clinical outcome of hepatocellular carcinoma
    Qiqi Tao
    Zhichao Lang
    Yifei Li
    Yuxiang Gao
    Lifan Lin
    Zhengping Yu
    Jianjian Zheng
    Suhui Yu
    BMC Cancer, 23 (1)